BRPI0416268A - composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla - Google Patents

composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla

Info

Publication number
BRPI0416268A
BRPI0416268A BRPI0416268-4A BRPI0416268A BRPI0416268A BR PI0416268 A BRPI0416268 A BR PI0416268A BR PI0416268 A BRPI0416268 A BR PI0416268A BR PI0416268 A BRPI0416268 A BR PI0416268A
Authority
BR
Brazil
Prior art keywords
methods
symptoms associated
delta
multiple sclerosis
treating symptoms
Prior art date
Application number
BRPI0416268-4A
Other languages
English (en)
Inventor
Robert E Dudley
Original Assignee
Unimed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals Inc filed Critical Unimed Pharmaceuticals Inc
Publication of BRPI0416268A publication Critical patent/BRPI0416268A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIçõES DE DELTA-9-THC E MéTODOS PARA O TRATAMENTO DE SINTOMAS ASSOCIADOS à ESCLEROSE MúLTIPLA. São proporcionados métodos, inter alia, para o tratamento e/ou prevenção de sintomas associados á esclerose múltipla e relapso de MS.
BRPI0416268-4A 2003-11-05 2004-11-04 composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla BRPI0416268A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51747903P 2003-11-05 2003-11-05
US98222904A 2004-11-03 2004-11-03
PCT/US2004/037149 WO2005044093A2 (en) 2003-11-05 2004-11-04 Delta-9- the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
BRPI0416268A true BRPI0416268A (pt) 2007-12-11

Family

ID=34576802

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416268-4A BRPI0416268A (pt) 2003-11-05 2004-11-04 composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla

Country Status (8)

Country Link
US (1) US20060167084A1 (pt)
EP (1) EP1696929A4 (pt)
JP (1) JP2007510736A (pt)
AU (1) AU2004287495A1 (pt)
BR (1) BRPI0416268A (pt)
CA (1) CA2544900A1 (pt)
MX (1) MXPA06005015A (pt)
WO (1) WO2005044093A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI436991B (zh) 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法
US8628796B2 (en) * 2004-12-09 2014-01-14 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
US20070060639A1 (en) * 2005-09-09 2007-03-15 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
EP2046290A4 (en) * 2006-08-04 2011-08-17 Insys Therapeutics Inc AQUEOUS DRONABINOL FORMULATIONS
US20080175902A1 (en) * 2006-11-30 2008-07-24 University Of Plymouth Methods for slowing the progression of multiple sclerosis
US20080181942A1 (en) * 2006-11-30 2008-07-31 University Of Plymouth Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US9775379B2 (en) 2010-12-22 2017-10-03 Syqe Medical Ltd. Method and system for drug delivery
CN104870421A (zh) * 2011-12-27 2015-08-26 比皮艾思药物研发有限公司 用于预防或治疗als的苯基氨基甲酸酯化合物
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
CA2952934A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
EP3160565B1 (en) 2014-06-30 2021-08-18 Syqe Medical Ltd. Devices and systems for pulmonary delivery of active agents
ES2904293T3 (es) 2014-06-30 2022-04-04 Syqe Medical Ltd Dispositivo para vaporización e inhalación de sustancias aisladas
KR102482733B1 (ko) 2014-06-30 2022-12-29 사이키 메디컬 엘티디. 유동 조절 흡입기 디바이스
AU2015283590B2 (en) 2014-06-30 2020-04-16 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
EP3160552B1 (en) 2014-06-30 2019-05-08 Syqe Medical Ltd. Drug dose cartridge for an inhaler device
ES2874087T3 (es) 2016-01-06 2021-11-04 Syqe Medical Ltd Tratamiento terapéutico con dosis bajas
WO2018002926A1 (en) 2016-06-28 2018-01-04 Seach Sarid Ltd. A dosage form for vaporization and smoking
US10307392B2 (en) 2017-10-21 2019-06-04 Alexander Kariman Compound and method for treatment of diseases and disorders
US10722545B2 (en) 2018-01-01 2020-07-28 Alexander Kariman Compound and method for treatment of movement disorders
WO2021055079A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
CN116075296A (zh) * 2020-07-01 2023-05-05 长矛治疗股份有限公司 用于治疗多发性硬化症的透皮药物制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703418B2 (en) * 1991-02-26 2004-03-09 Unimed Pharmaceuticals, Inc. Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
US6328992B1 (en) * 1997-03-03 2001-12-11 Lawrence L. Brooke Cannabinoid patch and method for cannabis transdermal delivery
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
JP2003504321A (ja) * 1999-07-08 2003-02-04 オーランド・ハン リポソーム被包カンナビノイドの肺送達
US20020111377A1 (en) * 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
US6503532B1 (en) * 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
GB2394894B (en) 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition

Also Published As

Publication number Publication date
WO2005044093A3 (en) 2005-09-22
US20060167084A1 (en) 2006-07-27
AU2004287495A1 (en) 2005-05-19
CA2544900A1 (en) 2005-05-19
JP2007510736A (ja) 2007-04-26
EP1696929A4 (en) 2010-02-24
EP1696929A2 (en) 2006-09-06
MXPA06005015A (es) 2007-11-22
WO2005044093A2 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
WO2005118511A3 (en) Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
ATE554114T1 (de) Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung
UA85559C2 (en) Aminobenzophenone compounds
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TNSN06022A1 (en) Use of calcitonin in osteoarthritis
EA200700717A1 (ru) Сульфонамиды
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
ECSP045021A (es) Terapia de combinacion para el tratamiento del cancer
TW200716088A (en) Formulations and methods for treating amyloidosis
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
DE60312211D1 (de) Haarbehandlungsmittel
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
SE0301650D0 (sv) Novel compounds
WO2005000208A3 (en) Combination therapy for the treatment of neoplasms
BRPI0506631B8 (pt) combinações, composição farmacêutica e usos das combinações
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
WO2007076320A8 (en) Compounds
WO2004105696A3 (en) Combination therapy for the treatment of neoplasms
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
TR200705146T1 (tr) Monoamin Yükselmesinin Engellenmesi
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
DE50309647D1 (de) Ng fibrotischer erkrankungen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.